Post-ERCP Pancreatitis Clinical Trial
Selective cannulation of common bile duct (CBD) by insertion of a guide-wire seems to be associated with fewer complications and post-ERCP (Endoscopic retrograde cholangiopancreatography) pancreatitis (PEP) rate than the conventional biliary tree access with cannulotome (CT-25 Cook Medical) with contrast injection even if results are conflicting. the aim of our study is to test a new guide-wire (loop-tip wire), with a loop in the tip, for the prevention of PEP and biliary tree access, in PEP high-risk patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02476279 -
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
|
Phase 3 | |
Completed |
NCT04876768 -
Effects of High FIO2 on Post-ERCP Pancreatitis.
|
N/A | |
Not yet recruiting |
NCT06250803 -
Early Pancreatic Stent Placement for Preventing PEP
|
N/A | |
Completed |
NCT01912716 -
Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis
|
Phase 2/Phase 3 | |
Terminated |
NCT00820612 -
Rectal Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High Risk Patients
|
Phase 4 | |
Recruiting |
NCT04750044 -
Refeeding in Post-ERCP Pancreatitis
|
N/A | |
Completed |
NCT03643900 -
The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis
|
N/A | |
Terminated |
NCT03749590 -
Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis.
|
Phase 3 | |
Recruiting |
NCT03708458 -
Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
|
Phase 4 |